Importance of early diagnostics of chronic obstructive pulmonary disease in patients with coronary heart disease
https://doi.org/10.15829/1728-8800-2011-3-47-50
Abstract
Aim. To study the specific clinical features in patients with coronary heart disease, CHD (stable effort angina, SEA) and chronic obstructive pulmonary disease (COPD), in order to improve early diagnostics of this combined pathology.
Material and methods. The study was a retrospective analysis of 958 medical histories. Co-existing COPD was registered in 251 patients (26,3 %). Therefore, Group I included 251 patients with SEA and COPD (26,3 %), while Group II included 707 SEA patients without COPD (73,7 %).
Results. In Group I, there were more men than women, by 5,7 % (р<0,05). No significant differences in age and angina functional class were observed between Groups I and II. In patients with SEA and COPD, the prevalence of arterial hypertension and myocardial infarction was higher than in Group II (р<0,05). In addition, Group I was characterised by higher prevalence of dyspnoea, palpitation, C-reactive protein elevation, and lipid metabolism disturbances.
Conclusion. Among chronic CHD patients hospitalized to the cardiology unit, co-existing COPD was registered in 26,3 %. The combination with COPD aggravated the clinical course of CHD. The study results support the use of lung function assessment in smoking CHD patients, to diagnose co-existing COPD.
About the Authors
A. N. KuznetsovRussian Federation
Nizniy Novgorod
N. Yu. Grigoryeva
Russian Federation
Nizniy Novgorod
E. G. Sharabrinv
Russian Federation
Nizniy Novgorod
References
1. Харламов В.В., Чупахина В.А., Пордников А.И. О частоте ишемической болезни сердца у больных хроническим бронхитом. Коронарная болезнь сердца, Красноярск 1982; 132-7.
2. Палеев Н.Р., Черейская Н.К. Ранняя диагностика ишемической болезни сердца у больных хроническими обструктивными заболеваниями легких. Тер архив 1999; 9: 52-6.
3. Вихерт А.М., Жданов В. С. Атеросклероз при различных заболеваниях. М: Медицина 1976.
4. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003; 107: 1514-9.
5. Авдеев С.Н., Баймаканова Г.Е. Стратегия ведения кардиологического пациента, страдающего ХОБЛ. Кардиопульмонологические взаимоотношения. Сердце 2007; 6 (6): 305-9.
6. Hole DJ, Watt GC, Davey-Smith G, et al. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996; 313: 711-75.
7. Задионченко В.С., Нестеренко О.И., Погонченкова И.В. и др. Коррекция эндотелиальной дисфункции у больных хроническим легочным сердцем ингибиторами ангиотензинпревращающего фермента. Серд недостат 2007; 1(7): 8-13.
8. Мухарлямов Н.М., Саттбеков Ж.С., Сучков В.В. Системная артериальная гипертензия у больных хроническими неспецифическими заболеваниями легких. Кардиология 1974; 12(34): 55-61.
9. Gan WQ, Man SF, Senthilselvan A, Sin DD. The association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59: 574-80.
10. Anthonisen NR, Connett JE, Enright PL, Manfreda J. Lung Health Study Research Group. Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med 2002; 166: 333-9.
11. Козлова Л.И. Хронические обструктивные заболевания легких и ишемическая болезнь сердца: некоторые аспекты функциональной диагностики. Пульмонология 2001; 2: 9-12.
Review
For citations:
Kuznetsov A.N., Grigoryeva N.Yu., Sharabrinv E.G. Importance of early diagnostics of chronic obstructive pulmonary disease in patients with coronary heart disease. Cardiovascular Therapy and Prevention. 2011;10(3):47-50. (In Russ.) https://doi.org/10.15829/1728-8800-2011-3-47-50